NCT06312735 is a NA clinical trial of VR (Reducept) in Chronic Pain, sponsored by University of Twente.

Who is sponsoring NCT06312735?

NCT06312735 is sponsored by University of Twente.

What drugs are being tested in NCT06312735?

Interventions in NCT06312735: VR (Reducept).

What condition does NCT06312735 study?

NCT06312735 studies Chronic Pain.

Is NCT06312735 still recruiting?

NCT06312735 is currently completed. Last updated 11 April 2025.

Last reviewed 2025-04-11 · How we verify

NCT06312735

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VR for Patients With Chronic Pain (Wait & Work)

Completed NA Last updated 11 April 2025

What this trial tests

NA trial testing VR (Reducept) in Chronic Pain in 53 participants. Completed in 30 November 2024.

Timeline

1 October 2023

Primary endpoint
30 April 2024

30 November 2024

Quick facts

Lead sponsor	University of Twente
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	53
Start date	1 October 2023
Primary completion	30 April 2024
Estimated completion	30 November 2024
Sites	4 locations across Netherlands

Drugs / interventions tested

VR (Reducept)

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

University of Twente

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This cluster-RCT evaluates the effect of therapeutic virtual reality (VR) on patients with chronic musculoskeletal pain (CMP) who are on a waiting list to receive pain treatment. The used VR application, Reducept, offers pain education and pain management techniques. This home-based, stand-alone, immersive VR intervention was used daily for four weeks in the intervention group. The control group received standard care (no treatment). Primary outcome measure for this study was health-related quality of life, secondary outcome measures included various pain-related variables (e.g. pain self-efficacy and acceptance. Outcome variables will be measured after four weeks and follow-up after six months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cluster-Randomised Controlled Trial of At-Home Virtual Reality for People With Chronic Musculoskeletal Pain on the Waiting List.
Slatman S, Heesink L, Achterkamp R, Broeks J, et al · · 2025 · cited 1× · PMID 40616335 · DOI 10.1002/ejp.70073

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other University of Twente trials

Trials by the same sponsor.

NCT07475260 — SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation · not yet recruiting
NCT06904976 — Nature-Focused Mindfulness and Spiritual Well-being Among Adults with Moderate Prolonged Grief Symptoms · NA · not yet recruiting
NCT06658340 — Feasibility of a Well-being Promotion Self-management Intervention in Post-COVID-19 Patients · NA · completed
NCT06365736 — The Effect of a Contemplative Nature-based Intervention on Spiritual Well-being · NA · completed
NCT05791760 — The Effectiveness of CFT for Reducing Self-criticism in Patients with Complex PTSD: a Single-case Experimental Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06312735 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Twente
Last refreshed: 11 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06312735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing